Abstract
Bifidobacterium bifidum, a key commensal promoting gastrointestinal health and immune function faces industrial challenges due to high osmotic pressure from acid accumulation during fermentation and water loss during freeze-drying. This study identified the strain B. bifidum CCFM1301 with superior osmotic pressure tolerance among 85 strains, using B. bifidum CCFM16 as a control. Inductively coupled plasma - mass spectrometry (ICP-MS) results indicated that B. bifidum CCFM1301 accumulated K+ to combat osmotic stress, while gas chromatography-mass spectrometry detection (GC-MS) analysis revealed an increase in unsaturated fatty acids (such as cyclopropane fatty acid) in its cell membrane. Non-targeted metabolomics suggested that B. bifidum CCFM1301 enhanced citric acid metabolism (with a fold change (FC) of 21.07 for citric acid), supporting membrane fatty acid synthesis. In contrast, B. bifidum CCFM16, with lower osmotic pressure tolerance, accumulated intracellular glutamate (FC=14.34) under stress. The study confirmed that exogenous K+, glutamate, and unsaturated fatty acids (oleic acid) improved osmotic stress resistance, measured by osmotic pressure, viable bacterial count, and freeze-drying survival rate. This research enables high-density fermentation and improves freeze-drying survival rate of B. bifidum, providing a foundation for its industrial application.